
Longeveron LGVN
$ 1.4
-3.45%
Annual report 2024
added 02-28-2025
Country |
![]() |
IPO year |
2021 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
9.41 B |
Market Cap[1] |
$ 13.2 B |
EBITDA (LTM) |
$ -16.6 M |
P/E (LTM) |
-0.34 |
P/S (LTM) |
25.11 |
EPS (LTM) |
-6.57 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.